Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1964 1
1968 1
1979 2
1980 1
1982 6
1983 2
1984 3
1985 4
1986 5
1987 5
1988 6
1989 7
1990 3
1991 8
1992 10
1993 18
1994 12
1995 11
1996 14
1997 19
1998 17
1999 15
2000 26
2001 22
2002 25
2003 32
2004 31
2005 38
2006 48
2007 53
2008 48
2009 59
2010 74
2011 90
2012 105
2013 118
2014 128
2015 155
2016 140
2017 177
2018 183
2019 231
2020 308
2021 300
2022 336
2023 376
2024 225

Text availability

Article attribute

Article type

Publication date

Search Results

3,168 results

Results by year

Filters applied: . Clear all
Page 1
Sintilimab Plus Chemotherapy for Unresectable Gastric or Gastroesophageal Junction Cancer: The ORIENT-16 Randomized Clinical Trial.
Xu J, Jiang H, Pan Y, Gu K, Cang S, Han L, Shu Y, Li J, Zhao J, Pan H, Luo S, Qin Y, Guo Q, Bai Y, Ling Y, Yang J, Yan Z, Yang L, Tang Y, He Y, Zhang L, Liang X, Niu Z, Zhang J, Mao Y, Guo Y, Peng B, Li Z, Liu Y, Wang Y, Zhou H; ORIENT-16 Investigators. Xu J, et al. Among authors: ling y. JAMA. 2023 Dec 5;330(21):2064-2074. doi: 10.1001/jama.2023.19918. JAMA. 2023. PMID: 38051328 Free PMC article. Clinical Trial.
Effects of Lianhuaqingwen Capsules in adults with mild-to-moderate coronavirus disease 2019: an international, multicenter, double-blind, randomized controlled trial.
Zheng JP, Ling Y, Jiang LS, Mootsikapun P, Lu HZ, Chayakulkeeree M, Zhang LX, Arttawejkul P, Hu FY, Truong TNL, Perez RA, Gu X, Sun HM, Jiang JJ, Liu RJ, Ding Z, Zhan YQ, Yang ZF, Guan WJ, Zhong NS. Zheng JP, et al. Among authors: ling y. Virol J. 2023 Nov 28;20(1):277. doi: 10.1186/s12985-023-02144-6. Virol J. 2023. PMID: 38017515 Free PMC article. Clinical Trial.
Editorial: Extracellular vesicles in gastrointestinal cancers.
Li L, Ling Y, Cheng Z, Hüser N, Cho WC. Li L, et al. Among authors: ling y. Front Oncol. 2023 Jul 4;13:1240002. doi: 10.3389/fonc.2023.1240002. eCollection 2023. Front Oncol. 2023. PMID: 37469416 Free PMC article. No abstract available.
Single-Cell Analysis Reveals Malignant Cells Reshape the Cellular Landscape and Foster an Immunosuppressive Microenvironment of Extranodal NK/T-Cell Lymphoma.
Li YQ, Luo CL, Jiang JX, He S, Liu Y, Yan WX, Xia Y, Cui Q, Huang Y, Lim JQ, Huang D, Hussein IN, Gao Y, Lin GW, Ling YH, Ma D, Zhang YT, Chan JY, Wei PP, Wang XX, Cheng CL, Xiong J, Zhao WL, Ong CK, Lim ST, Huang HQ, Peng RJ, Bei JX. Li YQ, et al. Among authors: ling yh. Adv Sci (Weinh). 2023 Dec;10(36):e2303913. doi: 10.1002/advs.202303913. Epub 2023 Nov 10. Adv Sci (Weinh). 2023. PMID: 37949673 Free PMC article.
Busulfan Plus Fludarabine Compared With Busulfan Plus Cyclophosphamide for AML Undergoing HLA-Haploidentical Hematopoietic Cell Transplantation: A Multicenter Randomized Phase III Trial.
Ling Y, Xuan L, Xu N, Huang F, Fan Z, Guo Z, Xu X, Liu H, Lin R, Yu S, Zhang H, Jin H, Wu M, Liu C, Liang X, Ou R, Zhang Y, Liu X, Qu H, Zhai X, Sun J, Zhao Y, Liu Q. Ling Y, et al. J Clin Oncol. 2023 Oct 10;41(29):4632-4642. doi: 10.1200/JCO.23.00101. Epub 2023 Jun 19. J Clin Oncol. 2023. PMID: 37335960 Clinical Trial.
3,168 results